The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
176
222: Private equity in autism care, a watershed...
First, STAT's Tara Bannow joins us to discuss how…
29 min
177
221: Big egos in Big Science, the return of Mer...
Are biotech's fortunes finally changing? Is Big S…
29 min
178
220: The last-minute push for drug pricing refo...
Is drug pricing reform really happening this time…
33 min
179
219: Helen Branswell on monkeypox, plus: an FDA...
Can monkeypox be contained? Are snortable Covid-1…
35 min
180
218: Well-paid CEOs, behind the scenes at Moder...
Does any CEO deserve $500 million a year? How did…
38 min
181
217: CRISPR for the heart, biotech's recovery, ...
Can CRISPR edit out a heart attack? What happens …
30 min
182
216: VC malaise, FDA confusion, & yet another A...
Is the era of the unicorn over? What's gotten int…
28 min
183
215: Medical privacy post-Roe, fixing clinical ...
How do you stop a Covid surge? Why are clinical t…
34 min
184
214: Juul's doomsday, Merck's buyout plans, & t...
Just how powerful is the FDA? Is Merck about to s…
27 min
185
213: How the Fed affects biotech, Paul Offit on...
Will biotech stocks ever recover? How well do Cov…
35 min
186
212: Applause-worthy cancer data, the long wait...
When is data "practice-changing"? How many Covid-…
35 min
187
211: Biotech's catch-22, a $100 genome, & deali...
Will gene therapy ever live up to expectations? C…
33 min
188
210: Covid vaccines for the youngest kids, ASCO...
ovid vaccines for the youngest kids are up for re…
34 min
189
Episode 209: Mysterious infections, dwindling C...
What happens when the White House runs out of Cov…
33 min
190
Episode 208: A CEO's arrest, Pfizer's big deal,...
Is the next Covid surge upon us? How do you make …
32 min
191
Episode 207: Succession at Biogen, surprises at...
Who's going to run Biogen? Does Aduhelm have a fu…
31 min
192
Episode 206: How cancer-killing cell therapies ...
Can rewired cells cure some patients' cancer? Do …
29 min
193
Episode 205: An ominous biotech deal, vaccines ...
Can buyouts be bad news? Why can't Novavax meet a…
32 min
194
Episode 204: Leana Wen on the pandemic's new no...
Are we supposed to just get used to superspreader…
38 min
195
Episode 203: What's next for Roche, a debate ov...
What's on tap for Roche and its closely followed …
33 min
196
Introducing: Color Code
As long as there's been a medical system, it's be…
29 min
197
Episode 202: Helen Branswell on the pandemic, p...
Are Covid-19 vaccines a sustainable business? Was…
35 min
198
Episode 201: Doing biotech in Ukraine, drug pri...
How should pharma treat Russia? Why can't Congres…
31 min
199
Episode 200: Gilead's growing pains, Covid's or...
Can biotech companies age gracefully? Where did C…
31 min
200
Episode 199: Biden's plans for Covid pills, the...
Is "test to treat" too good to be true? Does it r…
30 min